BRIEF published on 08/06/2024 at 22:10, 2 years ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 22:05, 2 years ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 2 years ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
PRESS RELEASE published on 07/15/2024 at 08:15, 2 years ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 2 years 1 month ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
PRESS RELEASE published on 07/03/2024 at 12:30, 2 years 1 month ago Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Published on 08/07/2026 at 23:15, 9 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 24 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 54 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 hour 9 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 14:17, 9 hours 7 minutes ago NuRAN Wireless Increases Series A Preferred Share Financing to C$7.6 Million and Announces Debt Settlements
Published on 08/07/2026 at 19:30, 3 hours 54 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 4 hours 9 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 5 hours 14 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 17:45, 5 hours 39 minutes ago Schroder ETFs ICAV: Publication of the Audited Annual Report for Switzerland
Published on 08/07/2026 at 17:34, 5 hours 50 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/07/2026 at 18:54, 4 hours 30 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 4 hours 44 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 5 hours 35 minutes ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 14 hours 54 minutes ago Disclosure of shares outstanding and voting rights - 07.08.2026
